Immune treatment for MS shows promise

A new treatment that boosts immunity to Epstein-Barr virus may benefit patients with multiple sclerosis, according to the results of an Australian study published in the Multiple Sclerosis Journal.In their study report, Michael Pender, a professor at the University of Queensland School of Medicine, Brisbane, and colleagues describe how a patient with advanced multiple sclerosis (MS) experienced noticeable clinical improvement after receiving 6 weeks of the immunotherapy treatment.